What Happened?
Shares of medical tech company CONMED (NYSE: CNMD) jumped 10.5% in the afternoon session after the company reported second-quarter adjusted earnings that beat analyst expectations and raised its full-year guidance.
The company's adjusted earnings for the quarter came in at $1.38 per share, a notable increase from $1.15 a year earlier and well above the $1.11 analysts had predicted. This strong performance, alongside revenue that also topped estimates, prompted management to raise its full-year adjusted EPS guidance to $4.54 at the midpoint and slightly lift its annual revenue forecast to $1.37 billion.
Is now the time to buy CONMED? Access our full analysis report here, it’s free.
What Is The Market Telling Us
CONMED’s shares are quite volatile and have had 17 moves greater than 5% over the last year. But moves this big are rare even for CONMED and indicate this news significantly impacted the market’s perception of the business.
The previous big move we wrote about was 17 days ago when the stock gained 9% on the news that reports revealed the company is exploring a potential sale. According to reports, the company is working with advisers to evaluate its options, including a sale, after receiving interest from private equity firms. The stock's move followed a significant jump in after-hours trading during the previous session when the news first broke. This suggests strong investor optimism about a potential deal.
CONMED is up 17.4% since the beginning of the year, but at $47.58 per share, it is still trading 14.7% below its 52-week high of $55.81 from August 2025. Despite the year-to-date gain, investors who bought $1,000 worth of CONMED’s shares 5 years ago would now be looking at only $344.96.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
